{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:12:22Z","timestamp":1762125142115,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1124\/dmd.108.020727","type":"journal-article","created":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T00:53:45Z","timestamp":1210640025000},"page":"1679-1688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Cytochrome P450 2B6 Catalyzes the Formation of Pharmacologically Active Sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) Metabolites in Human Liver Microsomes"],"prefix":"10.1016","volume":"36","author":[{"given":"Soo Kyung","family":"Bae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Ah","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hong","family":"Shon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Hyeon","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Gook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.108.020727_bib1","first-page":"345","article-title":"A pilot study to evaluate the pharmacokinetics of sibutramine in healthy subjects under fasting and fed conditions","volume":"7","author":"Abolfathi","year":"2004","journal-title":"J Pharmacol Pharm Sci"},{"key":"10.1124\/dmd.108.020727_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archinte.164.9.994","article-title":"The efficacy and safety of sibutramine for weight loss","volume":"164","author":"Arterburn","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1124\/dmd.108.020727_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1570-0232(02)00818-8","article-title":"Determination of the active metabolite of sibutramine by liquid chromatography-electrospray ionization mass spectrometry","volume":"785","author":"Chen","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/dmd.108.020727_bib4","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.bjp.0702446","article-title":"Thermogenic effects of sibutramine and its metabolites","volume":"126","author":"Connoley","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.108.020727_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2217\/14622416.8.6.547","article-title":"Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro","volume":"8","author":"Desta","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.108.020727_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(00)00216-8","article-title":"Enantioselective behavioral effects of sibutramine metabolites","volume":"397","author":"Glick","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"10.1124\/dmd.108.020727_bib7","first-page":"S18","article-title":"Sibutramine: a novel anti-obesity drug: a review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine","volume":"22","author":"Heal","year":"1998","journal-title":"Int J Obes"},{"key":"10.1124\/dmd.108.020727_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00008571-200404000-00002","article-title":"Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes","volume":"14","author":"Hesse","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.108.020727_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s002280050565","article-title":"Sibutramine pharmacokinetics in young and elderly healthy subjects","volume":"54","author":"Hind","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.108.020727_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.pharmthera.2006.10.002","article-title":"The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals","volume":"113","author":"Hodgson","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.108.020727_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200629040-00001","article-title":"Safety of drug therapies used for weight loss and treatment of obesity","volume":"29","author":"Ioannides-Demos","year":"2006","journal-title":"Drug Saf"},{"key":"10.1124\/dmd.108.020727_bib12","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/rcm.2760","article-title":"Liquid chromatography\/electrospray ionization tandem mass spectrometry validated method for the simultaneous quantification of sibutramine and its primary and secondary amine metabolites in human plasma and its application to a bioequivalence study","volume":"20","author":"Jain","year":"2006","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.108.020727_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5352\/JLS.2007.17.3.334","article-title":"Screening for inhibitory effect on nine CYP isoforms by 20 herbal medications","volume":"17","author":"Kim","year":"2007","journal-title":"Kor J Life Sci"},{"key":"10.1124\/dmd.108.020727_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.toxlet.2006.06.002","article-title":"Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028","volume":"166","author":"Kim","year":"2006","journal-title":"Toxicol Lett"},{"key":"10.1124\/dmd.108.020727_bib15","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/rcm.2110","article-title":"High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography\/tandem mass spectrometry","volume":"19","author":"Kim","year":"2005","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.108.020727_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00008571-200310000-00005","article-title":"Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6","volume":"13","author":"Kirchheiner","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.108.020727_bib17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/jpet.103.054866","article-title":"Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression","volume":"307","author":"Lamba","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.108.020727_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00008571-200107000-00004","article-title":"Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver","volume":"11","author":"Lang","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.108.020727_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/jpet.104.068973","article-title":"Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles","volume":"311","author":"Lang","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"10.1124\/dmd.108.020727_bib20","first-page":"S30","article-title":"Sibutramine: a review of clinical efficacy","volume":"21","author":"Lean","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1124\/dmd.108.020727_bib21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1124\/dmd.105.009134","article-title":"Stereoselective metabolism of endosulfan by human liver microsomes and human cytochrome P450 isoforms","volume":"34","author":"Lee","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020727_bib22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/jms.1082","article-title":"Metabolite profile of sibutramine in human urine: a liquid chromatography-electrospray ionization mass spectrometric study","volume":"41","author":"Link","year":"2006","journal-title":"J Mass Spectrom"},{"key":"10.1124\/dmd.108.020727_bib23","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1345\/aph.18319","article-title":"Sibutramine: a serotonin-norepinephrine reuptake inhibitor for the treatment of obesity","volume":"33","author":"Luque","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.108.020727_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0028-3908(89)90048-8","article-title":"The contribution of metabolites to the rapid and potent down regulation of rats cortical \u03b2-adrenoreceptors by the putative antidepressant sibutramine hydrochloride","volume":"28","author":"Luscombe","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1124\/dmd.108.020727_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FPC.0b013e328045c4fb","article-title":"Genetic polymorphisms of CYP2B6 affect the pharmacokinetics\/pharmacodynamics of cyclophosphamide in Japanese cancer patients","volume":"17","author":"Nakajima","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.108.020727_bib26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/dmd.106.012633","article-title":"Mechanism based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions","volume":"35","author":"Obach","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020727_bib27","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.clinthera.2004.12.012","article-title":"Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study","volume":"26","author":"Park","year":"2004","journal-title":"Clin Ther"},{"key":"10.1124\/dmd.108.020727_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1124\/jpet.103.056127","article-title":"Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine","volume":"308","author":"Richter","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.108.020727_bib29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1124\/dmd.30.10.1102","article-title":"Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoin","volume":"30","author":"Shin","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020727_bib30","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0090-9556(24)15029-5","article-title":"Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6","volume":"27","author":"Shin","year":"1999","journal-title":"Drug Metab Dispos"},{"issue":"Suppl 1","key":"10.1124\/dmd.108.020727_bib31","first-page":"S25","article-title":"Sibutramine: a review of the pharmacology of a novel anti-obesity agent","volume":"21","author":"Stock","year":"1997","journal-title":"Int J Obes"},{"key":"10.1124\/dmd.108.020727_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/138920006778520633","article-title":"The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico","volume":"7","author":"Turpeinen","year":"2006","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.108.020727_bib33","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1124\/dmd.107.015883","article-title":"A Comparison of 2-Phenyl-2-(1-piperidinyl)propane (PPP), 1,1\u2032,1\u2032\u2032-phosphinothioylidynetrisaziridine","volume":"35","author":"Walsky","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020727_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.tpj.6500157","article-title":"Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation","volume":"3","author":"Xie","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.108.020727_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01117450","article-title":"Application of the Akaike\u2019s Information Criterion in the evaluation of linear pharmacokinetic equations","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.108.020727_bib36","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1124\/dmd.106.013607","article-title":"Characterization of benidipine and its enantiomers\u2019 metabolism by human liver cytochrome P450 enzymes","volume":"35","author":"Yoon","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020727_bib37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/14622416.8.7.743","article-title":"Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance","volume":"8","author":"Zanger","year":"2007","journal-title":"Pharmacogenomics"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624017604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624017604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.108.020727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:28:11Z","timestamp":1739896091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624017604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0090955624017604"],"URL":"https:\/\/doi.org\/10.1124\/dmd.108.020727","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytochrome P450 2B6 Catalyzes the Formation of Pharmacologically Active Sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) Metabolites in Human Liver Microsomes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.108.020727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}